Crinetics Pharmaceuticals completes buyout by 2027 Q1
Resolves: Crinetics Pharmaceuticals announces the completion of its acquisition by an acquiring company, as confirmed by a press release or regulatory filing.
user-generated· earnings
Crinetics Pharmaceuticals completes buyout by 2027 Q1
Market overview
Crinetics Pharmaceuticals surged 40% on the buyout news, signaling strong investor confidence. The acquisition, likely by a larger biotech or pharma firm, is expected to close within 6 months given regulatory readiness.
earnings prediction market
- Implied probability (Yes)
- 80%
- Closes
- 2027-01-07
About this prediction
Resolution criteria
Crinetics Pharmaceuticals announces the completion of its acquisition by an acquiring company, as confirmed by a press release or regulatory filing.
Source: user-generated
More earnings markets
- Akamai's AI cloud revenue exceeds $500M in 2027 — 78% Yes
- Texas Roadhouse comp sales growth outpaces industry in Q3 2026 — 72% Yes
- SpaceX IPO valuation drops under $180B due to xAI dissolution concerns — 72% Yes
- Anthropic's enterprise AI revenue grows by 15% by Dec 2026 — 72% Yes
- SpaceX Q3 revenue exceeds executive guidance — 0% Yes
- Dessn reaches $50M ARR within 24 months — 70% Yes
- GM's AI-driven software revenue to exceed $2B by 2027 — 72% Yes
- Clio's ARR surpasses $750M by Q4 2026 — 72% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…